Corporate News 16-Feb-23
USFDA issues EIR for Piramal Pharma's Lexington facility
Piramal Pharma announced that the USFDA has issued an Establishment Inspection Report (EIR) for the company's manufacturing facility located at Lexington (Kentucky, USA) and the inspection has now been successfully closed by the USFDA.
Previous News
Piramal Pharma consolidated net profit rises 102.10% in the March 2024 quarter
( Results - Announcements 11-May-24 07:36 )
Piramal Pharma reports consolidated net profit of Rs 5.02 crore in the September 2023 quarter
( Results - Announcements 28-Oct-23 07:38 )
Piramal Pharma Q3 PAT drops 64% YoY to Rs 4 crore
( Hot Pursuit - 29-Jan-25 11:53 )
Piramal Pharma soars after Bethlehem facility gets USFDA clearance
( Hot Pursuit - 09-Nov-23 12:14 )
Board of Piramal Pharma recommends final dividend
( Corporate News - 11-May-24 09:40 )
Piramal Pharma to hold AGM
( Corporate News - 12-Jun-24 13:44 )
Piramal Pharma gains on appointing Sai Ramana Ponugoti as CEO of ICH
( Hot Pursuit - 07-Jan-25 11:43 )
Piramal Pharma to convene board meeting
( Corporate News - 02-May-24 11:16 )
Piramal Pharma arm launches new high-throughput screening facility in Ahmedabad
( Corporate News - 16-Oct-23 18:32 )
Piramal Pharma rises after USA facility clears USFDA inspection
( Hot Pursuit - 18-Apr-24 09:40 )
Piramal Pharma reports consolidated net loss of Rs 98.58 crore in the June 2023 quarter
( Results - Announcements 04-Aug-23 07:42 )
Other Stories
Hindustan Unilever AGM scheduled
24-Apr-25 21:11
Samhi Hotels to conduct EGM
24-Apr-25 21:11
Nestle India to hold AGM
24-Apr-25 21:10
Astec Lifesciences AGM scheduled
24-Apr-25 21:10
Shanthi Gears AGM scheduled
24-Apr-25 21:10
Solar Industries India receives affirmation in credit ratings from CRISIL
24-Apr-25 18:48
Sunrise Industrial Traders to hold board meeting
24-Apr-25 17:48
Fedbank Financial Services to announce Quarterly Result
24-Apr-25 17:47
Kranti Industries to hold board meeting
24-Apr-25 17:47
Mid East Portfolio Management EGM scheduled
24-Apr-25 17:47
Back
Top